South Korean shares rise 1% as pharmaceutical stocks jump

South Korean shares rose, with the KOSPI up nearly 1%, driven by a 3.97% surge in the pharmaceutical sector after the government pledged support against potential U.S. tariffs impacting key export industries like biopharmaceuticals and autos; Samsung Biologics notably gained 6.23% while the Korean Won strengthened 0.56% against the dollar, with foreigners net buyers of shares worth 113.7 billion won.

Analysis

South Korean equities, as measured by the KOSPI index (.KS11), registered a 0.99% gain to 2,627.63, primarily propelled by a significant 3.97% surge in the pharmaceutical sector (.KS32). This outperformance was directly linked to the South Korean government's pledge of increased support measures for key export industries, including biopharmaceuticals and autos, which face potential headwinds from U.S. tariffs. Within the pharmaceutical space, Samsung Biologics (207940.KS) was a standout performer, rallying 6.23%, while peer Celltrion (068270.KS) also saw a modest gain of 0.35%. Performance among other index heavyweights was mixed: chipmaker Samsung Electronics (005930.KS) rose 0.36%, whereas SK Hynix (000660.KS) declined 0.50% and battery maker LG Energy Solution (373220.KS) slid 0.36%. The automotive sector also showed divergence, with Hyundai Motor (005380.KS) down 0.32% and Kia Corp (000270.KS) up 0.66%, while steelmaker POSCO Holdings (005490.KS) remained flat. Market sentiment was further supported by net foreign buying amounting to 113.7 billion won, and the Korean won strengthened by 0.56% against the U.S. dollar, trading at 1,386.6. Conversely, bond markets indicated some caution, with yields on both the three-year and benchmark 10-year Korean treasury bonds rising by 1.5 and 5.1 basis points respectively, to 2.345% and 2.773%.

Key Decisions for Investors

• Investors should assess opportunities within the South Korean pharmaceutical sector, particularly for companies like Samsung Biologics, given the strong government commitment to mitigate U.S. tariff impacts and the sector's resultant positive momentum.
• Closely monitor developments regarding U.S. tariffs and the South Korean government's specific support measures for other export-oriented sectors such as automotive and technology, as their performance remains mixed despite broader support pledges.
• While net foreign inflows and a strengthening won offer positive signals for the broader market, the observed rise in domestic bond yields warrants attention as a potential indicator of shifting interest rate expectations or evolving risk sentiment.